Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria

Within the studied participants, there were clear absolute benefits of SGLT2 inhibitors on kidney, hospitalization, and mortality outcomes irrespective of diabetes status and level of UACR.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2025-11-07
DOI
https://doi.org/10.1001/jama.2025.20835
Citations
5
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
6.47
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria

Stefan D. Anker, Silvio E. Inzucchi, Milton Packer, Kieran F. Docherty et al.
5 citations
JAMA
Diabetes Treatment and Management
6.47
article

Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria

Stefan D. Anker, Silvio E. Inzucchi, Milton Packer, Kieran F. Docherty, Deepak L. Bhatt, Adrian F. Hernandez, Brendon Lange Neuen, Robert A. Fletcher, Javed Butler, John J.V. McMurray, Vlado Perkovic, Natalie Staplin, David Z.I. Cherney, Marc S. Sabatine, Hiddo J.L. Heerspink, David C. Wheeler, Christoph Wanner, Faiez M. Zannad, Kenneth W. Mahaffey, Siddharth M. Patel, Muthiah Vaduganathan, David Collins. Wheeler, Darren K. McGuire, Stefan Karl James, Bruce Charles Neal, William Guy Herrington, Alistair Roddick, Richard Haynes, Hiddo JL Heerspink, Meg Jardine, Stefan D. Anker, Vlado Perkovic, Scott D Solomon, Scott Solomon, Faı̈ez Zannad
article en
5 citations

Abstract

Within the studied participants, there were clear absolute benefits of SGLT2 inhibitors on kidney, hospitalization, and mortality outcomes irrespective of diabetes status and level of UACR.

JAMAVol. 335(3)
Brigham and Women's Hospital (US), The University of Sydney (AU), University Health Network (CA), University Medical Center Groningen (NL), Harvard University (US), Inserm (FR), University of Toronto (CA), Royal North Shore Hospital (AU), Baylor University Medical Center (US), Council for British Research in the Levant (GB), UNSW Sydney (AU), British Heart Foundation (GB), Yale University (US), University of Oxford (GB), Baylor Scott & White Medical Center - Temple (US), Smart Material (Germany) (DE), The George Institute for Global Health (AU), Universitätsklinikum Würzburg (DE), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Oxford University Hospitals NHS Trust (GB), Deutsches Herzzentrum München (DE), Center for Clinical Research (United States) (US), Thrombolysis in Myocardial Infarction Study Group (US), Berlin Heart (Germany) (DE), National Health and Medical Research Council (AU), University College London (GB), Imperial College London (GB), University of Glasgow (GB), The University of Texas Southwestern Medical Center (US), Université de Lorraine (FR), Stanford University (US)
Openalex Percentile: Top 3%
Diabetes Treatment and Management
6.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.